Lantis Laser is focused on developing and commercializing advanced technologies for applications in the dentistry industry. The Company has exclusive rights to the application of Optical Coherence Tomography (OCT) technology for dental diagnostic imaging through its license agreements with LightLab Imaging and Lawrence Livermore National Laboratory.
The company is currently in Phase II development of its first product, the “OCT Dental Imaging System”. The System has an unparalleled resolution of up to 10 times greater than traditional dental x-rays and is designed to provide early detection of tooth decay, periodontal disease and microstructural defects in teeth. Early detection gives the dentist the advantage to quickly halt or reverse the progress of diseases using non or minimally invasive procedures, consequently improving outcomes and enhancing the quality of patient care.
In conclusion, Beacon Equity Research’s analyst stated, “The Company expects to place 360 OCT System units in 2008 and anticipates triple-digit revenue growth and sales exceeding $71 million in 2011. Management’s estimates assume a very conservative 5% penetration rate in the first four years of marketing the product. Taking into account LLSR’s technology advantage, exclusive licenses and the huge potential market, we are initiating coverage of Lantis Laser, Inc. with a Speculative Buy rating and a $1.70 price target.”
Let us hear your thoughts:
